Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
33.43
-2.98 (-8.18%)
At close: Apr 1, 2025, 4:00 PM
35.11
+1.68 (5.02%)
After-hours: Apr 1, 2025, 7:59 PM EDT

Monopar Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
2041345314070
Upgrade
Market Cap Growth
2552.79%2552.79%-83.48%-24.23%-42.34%-59.48%
Upgrade
Enterprise Value
144128-3161852
Upgrade
Last Close Price
36.4122.001.7011.8516.0530.60
Upgrade
PB Ratio
4.042.440.913.042.134.47
Upgrade
P/TBV Ratio
2.442.440.913.042.134.47
Upgrade
Debt / Equity Ratio
---0.00--
Upgrade
Quick Ratio
11.4611.464.144.1912.8514.22
Upgrade
Current Ratio
11.4811.484.174.2112.9814.28
Upgrade
Return on Equity (ROE)
-51.42%-51.42%-107.19%-72.45%-52.57%-44.52%
Upgrade
Return on Assets (ROA)
-29.87%-29.87%-53.66%-39.03%-30.51%-26.92%
Upgrade
Return on Capital (ROIC)
-33.32%-33.32%-70.38%-45.36%-32.94%-28.73%
Upgrade
Earnings Yield
-7.65%-11.62%-166.13%-34.34%-22.52%-9.00%
Upgrade
Buyback Yield / Dilution
-37.09%-37.09%-8.70%-1.97%-13.82%-17.56%
Upgrade
Updated Nov 8, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q